In 2020, the Lancet Commission on Dementia Prevention, Intervention and Care published an updated report with a finding that stopped the field in its tracks: approximately 45% of dementia cases worldwide could potentially be prevented or delayed by addressing modifiable risk factors.
That number is worth sitting with. Not 4%. Not 14%. Forty percent of one of the most feared diseases of our time — potentially addressable through interventions that are, in most cases, accessible to anyone who takes them seriously.
But what does 45% actually mean, and which factors are on the list?
What “Potentially Preventable” Means
The 45% figure is a population attributable fraction — an estimate of how many dementia cases would be eliminated if specific risk factors were completely removed from the population. It doesn’t mean that any single person who addresses these factors will definitely avoid dementia. It means that across the full population, the cumulative contribution of these factors to dementia incidence is substantial.
The remaining 60% reflects factors we can’t currently modify — including genetics, aging itself, and biological processes not yet well understood. But 45% is not a ceiling. It’s a floor. As our understanding improves, that number is likely to rise.
The 45% figure is a population estimate, not a personal guarantee. But for an individual patient, the same logic applies: systematically addressing your modifiable risk factors meaningfully shifts your probability.
The 14 Modifiable Risk Factors
The 2024 update to the Lancet Commission report expanded the list from 12 to 14 modifiable risk factors, organized roughly by the life stage at which they are most impactful:
Early Life
- Less education — Lower educational attainment is associated with reduced cognitive reserve, which provides less buffer against pathological changes later in life.
Midlife (roughly ages 40–65)
- Hearing loss — One of the largest single contributors; untreated hearing loss accelerates cognitive decline through social isolation and increased cognitive load.
- High LDL cholesterol — Added in the 2024 update; elevated LDL in midlife correlates with increased amyloid deposition.
- Depression — Both a risk factor and an early symptom; the relationship is bidirectional.
- Traumatic brain injury — Even mild repeated concussions accumulate risk.
- Physical inactivity — Exercise is among the most robustly evidence-based brain health interventions we have.
- Diabetes — Metabolic dysregulation, insulin resistance, and vascular effects all contribute.
- Hypertension — Midlife hypertension in particular has a strong association with later dementia risk.
- Obesity — Associated with inflammation, metabolic syndrome, and vascular risk.
- Alcohol overconsumption — Directly neurotoxic at high intake; no level of consumption appears protective.
- Smoking — Vascular and direct neurological effects.
Later Life
- Social isolation — Loneliness is an independent dementia risk factor, with effects comparable in magnitude to physical inactivity.
- Air pollution — Emerging evidence on particulate matter and neuroinflammation.
- Vision loss — Added in 2024; uncorrected vision impairment, like hearing loss, reduces cognitive stimulation and social engagement.
“This list isn’t abstract public health data. It’s a clinical checklist — one I work through with every patient to identify where their personal leverage is highest.”
Why Most People Never See This List
Standard neurology practice doesn’t engage with these risk factors proactively. Neurologists typically see patients after symptoms appear. By that point, some of the most critical intervention windows — particularly those in midlife — have already passed.
This is the fundamental problem that preventive neurology is designed to solve. The Lancet framework isn’t hypothetical. It’s a practical roadmap for the kind of comprehensive risk assessment that should begin in the 30s and 40s, not in the 70s.
Individual Risk Is Not Population Risk
Here is where population statistics and individual medicine diverge in an important way. The 45% figure is an aggregate. Your personal risk profile is specific to you — your genetics, your metabolic health, your sleep, your cardiovascular history, your stress levels, your social engagement.
Some of the 14 factors will be highly relevant to you. Others won’t. The value of a comprehensive preventive neurology evaluation is precisely this: identifying which factors are most active in your specific profile and deploying targeted interventions in priority order, rather than applying a generic wellness protocol that treats everyone the same.
The 14 factors are a starting point for a personalized conversation, not a checklist to hand to a patient. The question isn’t just “which apply to you” — it’s “which are highest leverage for your specific biology and life stage.”
The Window That Matters Most
The Lancet data also clarifies something crucial about timing: midlife is the highest-leverage period. The pathological changes underlying Alzheimer’s begin decades before symptoms. The time to intervene on hypertension, hearing, metabolic health, and physical fitness is not when cognitive symptoms appear — it’s in your 40s and 50s, when the trajectory is still highly malleable.
This is why I built a practice focused specifically on this age group. Not because patients in their 70s can’t benefit — they can. But because the most powerful version of preventive neurology happens when there’s still time to substantially alter the course.
What to Do With This
If you read through the 14 factors and recognized several that apply to your life, that’s not cause for alarm — it’s cause for action. These are modifiable. That’s the entire point.
The most useful next step isn’t to try to address all 14 simultaneously. It’s to understand your specific risk profile with clinical precision, identify the two or three factors with the highest personal impact, and build a sustainable intervention plan around those first.